AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05309603 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Loaded Walking High
Description: Walking three miles on a treadmill at a self-selected speed while wearing a backpack with weight carried high on the back
Study NCT03737617 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cuvitru 20 % Injectable Solution
Description: Active
Study NCT05959174 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 3D printed mitchigen appliance
Description: the process of appliance construction done by intra-oral scanning of the arch and 3d printing
Study NCT04844502 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical rehabilitation
Description: Rehabilitation can be applied to the intervention group in two ways: in person or by home orientation. The face-to-face form will correspond to 5 weeks of intervention, 3 sessions per week, which should include: a) aerobic resistance training of 30 minutes in total, five minutes of cooling down); b) strengthening of peripheral muscles using 20-minute sessions of calisthenic exercises; and c) maintained active stretching, for 10 minutes, for the main muscle groups. The home-based intervention will correspond to three months of daily activities, monitored twice a week in the first month and once a week in the second and third months, by telephone or video conference, and will follow an exercise protocol that includes: a) aerobic resistance training for 15 uninterrupted minutes; b) anaerobic training to strengthen the peripheral muscles for 15 minutes at intervals with breathing exercises; and c) maintained active stretching, for 10 minutes, for the main muscle groups.
Study NCT04589442 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Split thickness skin graft
Description: standard of care graft
Study NCT04589442 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: microsurfaced split thickness skin graft
Description: standard of care graft that has been microsurfaced
Study NCT05309603 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Loaded Walking Mid
Description: Walking three miles on a treadmill at a self-selected speed while wearing a backpack with weight carried on the mid-back
Study NCT05309603 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Walking
Description: Walking three miles on a treadmill at a self-selected speed
Study NCT05487729 — intervention group
Intervention type: OTHER
Intervention: ultrasonography and functional assessment and questionnaire survey
Description: ultrasonography and functional assessment and questionnaire survey
Study NCT05959174 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: side chair appliance
Description: the impresion will be taken to make a cast to reconstruct the appliance
Study NCT04892875 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zimberelimab
Description: Zimberelimab will be administered at a dose of 360 mg IV on Day 1 of each 21-day cycle for up to 11 cycles.
Study NCT04892875 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etrumadenant
Description: Etrumadenant will be administered at a dose of 150 mg by mouth once daily on days 1-21 of each 21-day cycle for up to 11 cycles.
Study NCT04892875 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Concurrent weekly cisplatin and radiation will be administered as part of the subject's standard of care. Cisplatin and radiation will be initiated on the same day and continue for up to 7.5 weeks.
Study NCT04892875 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Concurrent weekly cisplatin and radiation will be administered as part of the subject's standard of care. Cisplatin and radiation will be initiated on the same day and continue for up to 7.5 weeks.
Study NCT04892875 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation
Description: Concurrent weekly cisplatin and radiation will be administered as part of the subject's standard of care. Cisplatin and radiation will be initiated on the same day and continue for up to 7.5 weeks.
Study NCT04892875 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation
Description: Concurrent weekly cisplatin and radiation will be administered as part of the subject's standard of care. Cisplatin and radiation will be initiated on the same day and continue for up to 7.5 weeks.
Study NCT04567849 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: message
Description: patient portal message
Study NCT04567849 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: provider
Description: nudging calling the patient's provider
Study NCT04567849 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: tele-nurse
Description: nudging calling the tele-nurse
Study NCT03986658 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Linear Asymmetric rTMS System
Description: Linear Asymmetric rTMS System
Study NCT05920057 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: constructive emotional management interventions
Description: The Constructive emotional management interventions sessions were conducted in the activity rooms of the elderly clubs where the researchers met the participants. Participants completed a baseline evaluation of the outcome measures of the researched variables after being found to be eligible for the current study and indicating their willingness to participate willingly. After explaining the study's objectives to participants, the researchers themselves delivered the Constructive Emotional Management Interventions program, which had been vetted by experts in the field.
Study NCT05334992 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy
Description: Individual therapy 12 to 16 weeks
Study NCT05334992 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavior Activation
Description: Individual therapy 12 to 16 weeks
Study NCT06474780 — intervention group
Intervention type: DEVICE
Intervention: Weight: 414g Size: 19.5cm x 14cm x 11cm Compatibility: Android and iOS VR Box 3.0 3D Virtual Reality Glasses Has the Feature of Fixation with Headband It has a lens mechanism tha
Description: Patients in the experimental group were fitted with virtual reality glasses for 3 cycles and were allowed to watch videos of city tours, walks in the forest, and nature walks for 15 minutes, depending on their choice.
Study NCT04926337 — intervention group
Intervention type: DEVICE
Intervention: Tight Fitting Facemask
Description: Preoxygenation with tight facemask, 10 L/min, 100% oxygen.
Study NCT04926337 — intervention group
Intervention type: DEVICE
Intervention: High Flow Nasal Oxygen (HFNO)
Description: Preoxygenation with high flow nasal oxygen, 40-70 L/min, 100% oxygen.
Study NCT06066359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine phosphate
Description: Given by (IV) vein
Study NCT06066359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given by (IV) vein
Study NCT06066359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NY-ESO-1 TCR/IL-15 NK
Description: Given by (IV) vein
Study NCT05689801 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire recovery time after a dialysis session.
Description: A very short questionnaire just after the dialysis session
Study NCT05689801 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SF-12 questionnaire
Description: Questionnaire about quality of life of the patient
Study NCT04914520 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VN-0200
Description: VN-0200 (antigen: VAGA-9001a, adjuvant: MABH-9002b) administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total
Study NCT04750889 — intervention group
Intervention type: DEVICE
Intervention: RFID tags
Description: Installation of the RFID tag device wire localization)
Study NCT04750889 — intervention group
Intervention type: DEVICE
Intervention: Wire localization
Description: Installation of the wire localization device
Study NCT04914520 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered as an intramuscular injection into the deltoid muscle of the upper arm; 2 injections total
Study NCT06090253 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gerotechnology enhanced multi-component exercise
Description: Intervention courses will be divided into 3 categories: Musculoskeletal training course, Neuromuscular and fall prevention training course, and cardiometabolic training course. The courses will be enabled by wearable technology, digital platform and visual display. Each of the courses will be 8 weeks in length (1 session per week), and 60 minutes per session.
Study NCT06090253 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based exercise
Description: The proposed elderly home gym training services will be conducted by professional fitness instructors and tailor-made for the participants. 4 personal training sessions will be assigned (once per week, 45 to 60 minutes per session).
Study NCT06090253 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Walking exercise
Description: Two interventions will be provided: A) Walk-focused intervention, B) Disease-related walk intervention for participants with chronic diseases.
Study NCT06090253 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Slow sports and exercise
Description: Participants will receive 10 training sessions (once or twice per week, 2 hours per session) conducted by professional fitness instructors. The training programs can be selected according to the participants' preference, including water exercises, stretching/fitness/gymnastics, slow walking/jogging, sports massage, Tai Chi, Yoga, etc.
Study NCT06090253 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Football
Description: The Football Training Programme will be arranged (10 training sessions+1 game day per stage, 4 stages per season). held on artificial turf football pitch or indoor sport facilities in 5 regions
Study NCT06438549 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HCP-CHW Integration into Prenatal Care for Smoking Cessation
Description: CHWs will be integrated into primary care, and subjects will receive CHW home visits (up to 8) that will provide brief behavioral smoking cessation interventions before, during, and after a quit date. This brief behavioral intervention will include watching a video and reviewing self-help materials.
Study NCT06438549 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Arm
Description: Standard of Care which provides referrals to community-based smoking cessation resources.
Study NCT05480280 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dalpiciclib
Description: Dalpiciclib is orally administered at 125mg qd for 21 days and discontinue for 7 days.
Study NCT05480280 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin injection
Description: 85mg/m², ivdrip, D1
Study NCT05576090 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation
Description: The mindful awareness practices (MAPS) for Sleep intervention is based on an institutional program developed by the Mindful Awareness Research Center (MARC) at UCLA. This intervention includes educational and behavioral content related to sleep, including the importance of regularity of sleep schedules, minimizing noise and light, and reducing caffeine use later in the day. Each session provides structured training and exercises in mindfulness, including formal meditation practices and strategies for the daily informal use of mindfulness, as well as opportunity for questions and group discussion. Home practice is a key component of MAPs and is particularly important for addressing sleep disturbance. Participants will be instructed to practice mindfulness techniques on a daily basis, beginning with five minutes and increasing to 20 minutes, with practice prior to bedtime, and to practice at night if they awake and cannot return to sleep.
Study NCT05480280 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium folinate
Description: 400mg/m², ivdrip, D1; or calcium levofolinate, 200 mg/m², ivdrip, D1
Study NCT05480280 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Description: 400mg/m², iv, D1; and 2400mg/m², civ, 46-48h
Study NCT05689801 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L Questionnaire
Description: Questionnaire about quality of life of the patient
Study NCT05689801 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pittman, John et McIntyre questionnaire
Description: Questionnaire about quality of life of the patient under dialysis
Study NCT05689801 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional hemodialysis
Description: patient on polyethersulfone membrane dialysis (Revaclear®, Baxter) with HemoControl™ for 12 weeks
Study NCT05689801 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Optimized hemodialysis
Description: patient on Medium Cut-Off membrane dialysis (Theranova®, Baxter) with HemoControl™ for 12 weeks.
Study NCT05346458 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intra coronary rapid-exchange iKOs microcatheter intervention
Description: Patients planned for an invasive coronary physiology (pressure-wire) study and who meet the inclusion criteria and none of the exclusion criteria can be enrolled. Participants will undergo preparation for their clinical procedure (angiogram with pressure wire study) in the normal manner. Arterial cannulation will be performed via the radial or femoral artery) under local anaesthesia. The sheath will be inserted and a pre-procedure blood sample taken for Troponin T level. A coronary angiogram will be performed as per standard clinical practice prior to cannulating the coronary artery to be studied. The pressure studies will be performed sequentially, first with a pressure wire before using the iKOs™ microcatheter. Following withdrawal of the iKOs™ microcatheter. A pressure wire assessment is repeated after the microcatheter is withdrawn. The case will then proceed as clinically indicated. Post-procedure the participant will be managed according to standard clinical practice.
Study NCT05723406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex 100 MG/ML [Bridion]
Description: 8 mg/ml
Study NCT05723406 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sodium 0.9% 5 ml
Study NCT06429813 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-Based Exercise Intervention - Walking
Description: 30 minutes of walking or light jogging a day at a moderate intensity for 30 minutes a day, 5 days a week for 12 weeks
Study NCT06429813 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-Based Exercise Intervention - HIIT Cycling
Description: Four, 4 minute high intensity intervals of exercise, separated by 3 minutes of lower intensity exercise + a 10 minute warm up and 5 minute cool down for 40 minutes a day, 3 days a week for 12 weeks
Study NCT05936775 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nano-hydroxy apatite coated titanium implants
Description: titanium implants with surface treatment of nano-hydroxy apatite
Study NCT05936775 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: sandblasted large acid itched coated titanium implant
Description: titanium implants with SLA surface treatment
Study NCT04746001 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Genomic sequencing
Description: Sequencing data
Study NCT04746001 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Histological examination
Description: Images for deep learning
Study NCT04567680 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy to Improve Social Support for Veterans with PTSD
Description: This treatment is designed to help Veterans with PTSD increase social support in family, partner, and peer relationships by reducing experiential avoidance. ACT-SS is specifically designed to address deficits in the entire social support network for Veterans with PTSD.
Study NCT04567680 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Present-Centered Therapy
Description: PCT is designed to provide the emotional support for individuals with PTSD that will assist with recovery. The focus of PCT is on the here and now, including current life difficulties that are directly or indirectly related to the experience of trauma. PCT aims to help the patient consider ways to react to these difficulties.
Study NCT05934409 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bariatric surgery
Description: Laparoscopic Sleeve Gastrectomy
Study NCT05934409 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Description: Laparoscopic Sleeve Gastrectomy
Study NCT05934409 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotinic Acid
Description: Only during A1. 150mg every half hour for 6 hours. A total dose of 1800mg will be ingested.
Study NCT05934409 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotinic Acid
Description: Only during A1. 150mg every half hour for 6 hours. A total dose of 1800mg will be ingested.
Study NCT04768881 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor
Description: Dose and formulation: 80 mg (4 tablets of 20 mg)
Study NCT04768881 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Dose and formulation: 400 mg (25 milligrams per milliliter \[mg/mL\]) Solution
Study NCT06509048 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: STN-DBS Theta Gamma Stimulation
Description: Standard STN-DBS stimulation with addiction of bilateral theta frequency stimulation of ventral contacts
Study NCT05685355 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Standardized intraoral photography
Description: Mouth photos will be taken with a plastic retractor to retract the subject's cheek and lips. This is a standard clinical procedure that is non-invasive and does not cause any harm or adverse effect on subjects.
Study NCT05576090 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sleep Education
Description: The Sleep Education intervention provides education and behavioral content based on the National Institutes of Health and National Sleep Foundation tips for better sleep (e.g., changing poor sleep habits and establishing a bedtime routine). Each session provides didactic instruction, review of behavioral techniques, and opportunity for questions. Homework includes practicing sleep hygiene and weekly reading. Key components of the intervention include information about sleep biology, characteristics of healthy and unhealthy sleep, sleep problems, stress biology and stress reduction, self-monitoring of sleep behavior, relaxation methods for improving sleep, and weekly behavioral sleep hygiene strategies.
Study NCT05744167 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BFRT
Description: Following a warm-up of 10 min, subjects in the experimental group will undergo BFRT for two times per week, consisting of lower extremity exercises (leg press, knee extension, knee flexion). BFRT will be at 40% of 1 repetition maximum (1RM); The volume % (V% = number of repetitions x number of sets x number of exercises x % 1 repetition max) = 57.6%. Progression during the 12 week program will be attained by a 1RM test every 4 weeks.
Study NCT05744167 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MDRT
Description: Following a warm-up of 10 min, subjects in the experimental group will undergo MDRT for two times per week, consisting of lower extremity exercises (leg press, knee extension, knee flexion). The exercise will be at 80% of 1RM concentric-only or 120% of 1RM eccentric-only in a 3:1 ratio. The volume % (V% = number of repetitions x number of sets x number of exercises x % 1 repetition max) = 57.6%. Progression during the 12 week program will be attained by a 1RM test every 4 weeks.
Study NCT04944173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Subjects will receive durvalumab 1500mg IV every four weeks for four cycles, undergo assessment for residual disease, then a subset of subjects will receive an additional eight cycles of durvalumab.
Study NCT04905056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ablation therapy
Description: Ablation therapy in the treatment of lung cancer presenting as ground-glass nodules
Study NCT05132764 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Microosteoperforations
Description: 2 inter radicular bone microosteoperforations using temporary anchorage device tip.
Study NCT05452733 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: differences of behavior between sleepwalking and non sleepwalking patient
Description: movement registry done by camera when low intensity sound are send to patient during sleep.
Study NCT05452733 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: differences of behavior between sleepwalking and non sleepwalking patient
Description: movement registry done by camera when low intensity sound are send to patient during sleep.